Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Role of Epigenetics in Cardiac Development and Congenital Diseases.

Moore-Morris T, van Vliet PP, Andelfinger G, Puceat M.

Physiol Rev. 2018 Oct 1;98(4):2453-2475. doi: 10.1152/physrev.00048.2017.

PMID:
30156497
2.

Geometrical confinement controls the asymmetric patterning of brachyury in cultures of pluripotent cells.

Blin G, Wisniewski D, Picart C, Thery M, Puceat M, Lowell S.

Development. 2018 Sep 21;145(18). pii: dev166025. doi: 10.1242/dev.166025.

3.

Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation.

Chatzifrangkeskou M, Yadin D, Marais T, Chardonnet S, Cohen-Tannoudji M, Mougenot N, Schmitt A, Crasto S, Di Pasquale E, Macquart C, Tanguy Y, Jebeniani I, Pucéat M, Morales Rodriguez B, Goldmann WH, Dal Ferro M, Biferi MG, Knaus P, Bonne G, Worman HJ, Muchir A.

Hum Mol Genet. 2018 Sep 1;27(17):3060-3078. doi: 10.1093/hmg/ddy215.

PMID:
29878125
4.

Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages.

Moore-Morris T, Cattaneo P, Guimarães-Camboa N, Bogomolovas J, Cedenilla M, Banerjee I, Ricote M, Kisseleva T, Zhang L, Gu Y, Dalton ND, Peterson KL, Chen J, Pucéat M, Evans SM.

Circ Res. 2018 Feb 16;122(4):583-590. doi: 10.1161/CIRCRESAHA.117.311490. Epub 2017 Dec 21.

PMID:
29269349
5.

Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria.

Suffee N, Moore-Morris T, Farahmand P, Rücker-Martin C, Dilanian G, Fradet M, Sawaki D, Derumeaux G, LePrince P, Clément K, Dugail I, Puceat M, Hatem SN.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E771-E780. doi: 10.1073/pnas.1610968114. Epub 2017 Jan 17.

6.

Twelfth Annual Meeting of the French Society of Cell and Gene Therapy.

Verhoeyen E, Gomez S, Galy A, Ayuso E, Midoux P, Pucéat M, Vassaux G, Cordelier P.

Hum Gene Ther. 2016 Jul;27(7):555-8. doi: 10.1089/hum.2016.29031.eve. No abstract available.

PMID:
27428658
7.

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues.

Jebeniani I, Leschik J, Puceat M.

J Vis Exp. 2016 Jun 3;(112). doi: 10.3791/53874.

8.

Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis.

Faustino RS, Behfar A, Groenendyk J, Wyles SP, Niederlander N, Reyes S, Puceat M, Michalak M, Terzic A, Perez-Terzic C.

J Mol Cell Cardiol. 2016 Mar;92:63-74. doi: 10.1016/j.yjmcc.2016.01.022. Epub 2016 Jan 27.

PMID:
26826378
9.

Origins of cardiac fibroblasts.

Moore-Morris T, Cattaneo P, Puceat M, Evans SM.

J Mol Cell Cardiol. 2016 Feb;91:1-5. doi: 10.1016/j.yjmcc.2015.12.031. Epub 2015 Dec 31. Review.

10.

Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction.

Calderon D, Prot M, You S, Marquet C, Bellamy V, Bruneval P, Valette F, de Almeida P, Wu JC, Pucéat M, Menasché P, Chatenoud L.

Am J Transplant. 2016 Feb;16(2):454-67. doi: 10.1111/ajt.13477. Epub 2015 Oct 22.

11.

Mitral valve disease--morphology and mechanisms.

Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunemaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott JJ, Schwammenthal E, Slaugenhaupt SA, Song JK, Yacoub MH; Leducq Mitral Transatlantic Network.

Nat Rev Cardiol. 2015 Dec;12(12):689-710. doi: 10.1038/nrcardio.2015.161. Epub 2015 Oct 20. Review.

12.

Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?

Gouadon E, Moore-Morris T, Smit NW, Chatenoud L, Coronel R, Harding SE, Jourdon P, Lambert V, Rucker-Martin C, Pucéat M.

Stem Cells. 2016 Jan;34(1):34-43. doi: 10.1002/stem.2205. Epub 2015 Sep 16. Review.

13.

Mutations in DCHS1 cause mitral valve prolapse.

Durst R, Sauls K, Peal DS, deVlaming A, Toomer K, Leyne M, Salani M, Talkowski ME, Brand H, Perrocheau M, Simpson C, Jett C, Stone MR, Charles F, Chiang C, Lynch SN, Bouatia-Naji N, Delling FN, Freed LA, Tribouilloy C, Le Tourneau T, LeMarec H, Fernandez-Friera L, Solis J, Trujillano D, Ossowski S, Estivill X, Dina C, Bruneval P, Chester A, Schott JJ, Irvine KD, Mao Y, Wessels A, Motiwala T, Puceat M, Tsukasaki Y, Menick DR, Kasiganesan H, Nie X, Broome AM, Williams K, Johnson A, Markwald RR, Jeunemaitre X, Hagege A, Levine RA, Milan DJ, Norris RA, Slaugenhaupt SA.

Nature. 2015 Sep 3;525(7567):109-13. doi: 10.1038/nature14670. Epub 2015 Aug 10.

14.

Cardiac fibroblasts: from development to heart failure.

Moore-Morris T, Guimarães-Camboa N, Yutzey KE, Pucéat M, Evans SM.

J Mol Med (Berl). 2015 Aug;93(8):823-30. doi: 10.1007/s00109-015-1314-y. Epub 2015 Jul 14. Review.

15.

Msx1CreERT2 knock-In allele: A useful tool to target embryonic and adult cardiac valves.

Papoutsi T, Odelin G, Moore-Morris T, Pucéat M, de la Pompa JL, Robert B, Zaffran S.

Genesis. 2015 May;53(5):337-45. doi: 10.1002/dvg.22856.

PMID:
25950518
16.

A cohesin-OCT4 complex mediates Sox enhancers to prime an early embryonic lineage.

Abboud N, Moore-Morris T, Hiriart E, Yang H, Bezerra H, Gualazzi MG, Stefanovic S, Guénantin AC, Evans SM, Pucéat M.

Nat Commun. 2015 Apr 8;6:6749. doi: 10.1038/ncomms7749.

17.

Right ventricular failure secondary to chronic overload in congenital heart diseases: benefits of cell therapy using human embryonic stem cell-derived cardiac progenitors.

Lambert V, Gouadon E, Capderou A, Le Bret E, Ly M, Dinanian S, Renaud JF, Pucéat M, Rücker-Martin C.

J Thorac Cardiovasc Surg. 2015 Mar;149(3):708-15.e1. doi: 10.1016/j.jtcvs.2014.11.033. Epub 2014 Nov 25.

18.

Targeting cardiac fibroblasts: the pressure is on.

Moore-Morris T, Pucéat M, Evans SM.

Cell Cycle. 2014;13(17):2647-8. doi: 10.4161/15384101.2014.954212. No abstract available.

19.

Response to letter regarding article, "Embryonic stem cell-derived cardiac myocytes are not ready for human trials".

Sussman MA, Puceat M.

Circ Res. 2014 Oct 24;115(10):e30-1. doi: 10.1161/CIRCRESAHA.114.305341. No abstract available.

PMID:
25342772
20.

A view of bivalent epigenetic marks in two human embryonic stem cell lines reveals a different cardiogenic potential.

Leschik J, Caron L, Yang H, Cowan C, Pucéat M.

Stem Cells Dev. 2015 Feb 1;24(3):384-92. doi: 10.1089/scd.2014.0345. Epub 2014 Oct 29.

PMID:
25202820
21.

MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential.

Richart A, Loyer X, Néri T, Howangyin K, Guérin CL, Ngkelo A, Bakker W, Zlatanova I, Rouanet M, Vilar J, Lévy B, Rothenberg M, Mallat Z, Pucéat M, Silvestre JS.

Stem Cells. 2014 Nov;32(11):2908-22. doi: 10.1002/stem.1789.

22.

Embryonic stem cell-derived cardiac myocytes are not ready for human trials.

Anderson ME, Goldhaber J, Houser SR, Puceat M, Sussman MA.

Circ Res. 2014 Jul 18;115(3):335-8. doi: 10.1161/CIRCRESAHA.114.304616. Epub 2014 Jun 16. No abstract available.

23.

Cell labeling and injection in developing embryonic mouse hearts.

Hiriart E, van Vliet P, Dirschinger RJ, Evans SM, Puceat M.

J Vis Exp. 2014 Apr 17;(86). doi: 10.3791/51356.

24.

Could a pluripotent stem cell give rise to a high yield of a single cell lineage: a myocardial cell?

Puceat M.

Curr Opin Genet Dev. 2013 Aug;23(4):498-9. doi: 10.1016/j.gde.2013.06.001. Epub 2013 Jul 10. No abstract available.

PMID:
23850377
25.

Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy.

Catelain C, Riveron S, Papadopoulos A, Mougenot N, Jacquet A, Vauchez K, Yada E, Pucéat M, Fiszman M, Butler-Browne G, Bonne G, Vilquin JT.

Mol Ther. 2013 May;21(5):1064-75. doi: 10.1038/mt.2013.15. Epub 2013 Feb 26.

26.

Long-term functional benefits of epicardial patches as cell carriers.

Hamdi H, Planat-Benard V, Bel A, Neamatalla H, Saccenti L, Calderon D, Bellamy V, Bon M, Perrier MC, Mandet C, Bruneval P, Casteilla L, Hagège AA, Pucéat M, Agbulut O, Menasché P.

Cell Transplant. 2014 Jan;23(1):87-96. doi: 10.3727/096368912X658836. Epub 2012 Nov 1.

PMID:
23127387
27.

Embryological origin of the endocardium and derived valve progenitor cells: from developmental biology to stem cell-based valve repair.

Pucéat M.

Biochim Biophys Acta. 2013 Apr;1833(4):917-22. doi: 10.1016/j.bbamcr.2012.09.013. Epub 2012 Oct 16. Review.

28.

Early cardiac development: a view from stem cells to embryos.

Van Vliet P, Wu SM, Zaffran S, Pucéat M.

Cardiovasc Res. 2012 Dec 1;96(3):352-62. doi: 10.1093/cvr/cvs270. Epub 2012 Aug 14. Review.

29.

[Pluripotent stem cells: a cell model for early cardiac development].

Pucéat M.

Biol Aujourdhui. 2012;206(1):25-9. doi: 10.1051/jbio/2012001. Epub 2012 Apr 3. Review. French.

PMID:
22463993
30.

Regulation of skin aging and heart development by TAp63.

Paris M, Rouleau M, Pucéat M, Aberdam D.

Cell Death Differ. 2012 Feb;19(2):186-93. doi: 10.1038/cdd.2011.181. Epub 2011 Dec 9. Review.

31.

[Unexpected role for p63 during heart development: one phenotype can hide another one].

Rouleau M, Pucéat M, Aberdam D.

Med Sci (Paris). 2011 Oct;27(10):905-9. doi: 10.1051/medsci/20112710023. Epub 2011 Oct 21. Review. French. No abstract available.

32.

TAp63 is important for cardiac differentiation of embryonic stem cells and heart development.

Rouleau M, Medawar A, Hamon L, Shivtiel S, Wolchinsky Z, Zhou H, De Rosa L, Candi E, de la Forest Divonne S, Mikkola ML, van Bokhoven H, Missero C, Melino G, Pucéat M, Aberdam D.

Stem Cells. 2011 Nov;29(11):1672-83. doi: 10.1002/stem.723.

33.

Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells.

Calderon D, Planat-Benard V, Bellamy V, Vanneaux V, Kuhn C, Peyrard S, Larghero J, Desnos M, Casteilla L, Pucéat M, Menasché P, Chatenoud L.

J Cell Mol Med. 2012 Jul;16(7):1544-52. doi: 10.1111/j.1582-4934.2011.01435.x.

34.

Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue.

Habeler W, Ghaleh B, Barthelemy I, Plancheron A, Bizé A, Carlos-Sampedrano C, Chetboul V, Berdeaux A, Pucéat M, Peschanski M, Blot S, Monville C.

J Stem Cells Regen Med. 2011 Oct 30;7(2):80-6. eCollection 2011.

35.

Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.

Bel A, Planat-Bernard V, Saito A, Bonnevie L, Bellamy V, Sabbah L, Bellabas L, Brinon B, Vanneaux V, Pradeau P, Peyrard S, Larghero J, Pouly J, Binder P, Garcia S, Shimizu T, Sawa Y, Okano T, Bruneval P, Desnos M, Hagège AA, Casteilla L, Pucéat M, Menasché P.

Circulation. 2010 Sep 14;122(11 Suppl):S118-23. doi: 10.1161/CIRCULATIONAHA.109.927293.

PMID:
20837902
36.

Cardiac regeneration: still a 21st century challenge in search for cardiac progenitors from stem cells and embryos.

Neri T, Stefanovic S, Pucéat M.

J Cardiovasc Pharmacol. 2010 Jul;56(1):16-21. doi: 10.1097/FJC.0b013e3181d8bc6d. Review.

PMID:
20631550
37.

Calmodulin: a gatekeeper for ryanodine receptor function in the myocardium.

Pucéat M.

Cardiovasc Res. 2010 Sep 1;87(4):587-8. doi: 10.1093/cvr/cvq215. Epub 2010 Jun 29. No abstract available.

PMID:
20587508
38.

[The dual role of OCT4].

Stefanovic S, Pucéat M.

Med Sci (Paris). 2010 Apr;26(4):411-6. doi: 10.1051/medsci/2010264411. Review. French.

39.

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rücker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagège A, Desnos M, Renaud JF, Menasché P, Pucéat M.

J Clin Invest. 2010 Apr;120(4):1125-39. doi: 10.1172/JCI40120. Epub 2010 Mar 24.

40.

Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology.

Blin G, Neri T, Stefanovic S, Pucéat M.

Curr Stem Cell Res Ther. 2010 Sep;5(3):215-26. Review.

PMID:
20214559
41.

Nano-scale control of cellular environment to drive embryonic stem cells selfrenewal and fate.

Blin G, Lablack N, Louis-Tisserand M, Nicolas C, Picart C, Pucéat M.

Biomaterials. 2010 Mar;31(7):1742-50. doi: 10.1016/j.biomaterials.2009.11.055. Epub 2009 Dec 3.

PMID:
19962191
42.

Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate.

Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Pucéat M.

J Cell Biol. 2009 Sep 7;186(5):665-73. doi: 10.1083/jcb.200901040.

43.

Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction.

Léobon B, Roncalli J, Joffre C, Mazo M, Boisson M, Barreau C, Calise D, Arnaud E, André M, Pucéat M, Pénicaud L, Prosper F, Planat-Bénard V, Casteilla L.

Cardiovasc Res. 2009 Sep 1;83(4):757-67. doi: 10.1093/cvr/cvp167. Epub 2009 Jun 8.

PMID:
19505931
44.

Human embryonic stem cells and cardiac cell fate.

Nury D, Neri T, Pucéat M.

J Cell Physiol. 2009 Mar;218(3):455-9. doi: 10.1002/jcp.21631. Review.

PMID:
19006174
45.

An in vitro beating heart model for long-term assessment of experimental therapeutics.

Habeler W, Pouillot S, Plancheron A, Pucéat M, Peschanski M, Monville C.

Cardiovasc Res. 2009 Feb 1;81(2):253-9. doi: 10.1093/cvr/cvn299. Epub 2008 Nov 3.

PMID:
18980954
46.

The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy.

Leist M, Bremer S, Brundin P, Hescheler J, Kirkeby A, Krause KH, Poerzgen P, Puceat M, Schmidt M, Schrattenholz A, Zak NB, Hentze H.

ALTEX. 2008;25(3):163-90.

47.

Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?

Puymirat E, Geha R, Tomescot A, Bellamy V, Larghero J, Trinquart L, Bruneval P, Desnos M, Hagège A, Pucéat M, Menasché P.

Mol Ther. 2009 Jan;17(1):176-82. doi: 10.1038/mt.2008.208. Epub 2008 Oct 7.

48.

Cardiac commitment of primate embryonic stem cells.

Leschik J, Stefanovic S, Brinon B, Pucéat M.

Nat Protoc. 2008;3(9):1381-7. doi: 10.1038/nprot.2008.116.

PMID:
18772864
49.

Protocols for cardiac differentiation of embryonic stem cells.

Pucéat M.

Methods. 2008 Jun;45(2):168-71. doi: 10.1016/j.ymeth.2008.03.003. Epub 2008 May 29. Review.

PMID:
18593613
50.

[FISCH-ESC, the first international symposium on human embryonic stem cell research].

Coulombel L, De Vos J, Pucéat M.

Med Sci (Paris). 2008 Apr;24(4):419-26. doi: 10.1051/medsci/2008244419. French. No abstract available.

Supplemental Content

Loading ...
Support Center